Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
InfuSystem Holdings
INFU
$185M
| $940K | ﹤0.01% |
45,167
+6,855
| +18% | +$139K |
|
2952
CNB Financial Corp
CCNE
$1.04B
| $939K | ﹤0.01% |
41,138
+2,184
| +6% | +$53.3K |
|
|
ZIXI
2953
DELISTED
Zix Corporation
ZIXI
| $938K | ﹤0.01% |
132,920
-3,552
| -3% | -$25.7K |
|
|
DRRX
2954
DELISTED
DURECT Corp
DRRX
| $936K | ﹤0.01% |
57,399
+2,629
| +5% | +$45.9K |
|
|
XONE
2955
DELISTED
The ExOne Company
XONE
| $935K | ﹤0.01% |
43,192
+7,788
| +22% | +$177K |
|
2956
Cartesian Therapeutics
RNAC
$227M
| $933K | ﹤0.01% |
7,439
+1,471
| +25% | +$175K |
|
2957
Southern First Bancshares
SFST
$579M
| $933K | ﹤0.01% |
18,232
-45
| -0.2% | -$2.33K |
|
|
XIFR
2958
XPLR Infrastructure LP
XIFR
$1.12B
| $928K | ﹤0.01% |
12,158
-1,469
| -11% | -$105K |
|
|
WMC
2959
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $926K | ﹤0.01% |
28,463
-12,909
| -31% | -$428K |
|
2960
Forte Biosciences
FBRX
$1.58B
| $925K | ﹤0.01% |
+1,100
| New | +$991K |
|
|
HYRE
2961
DELISTED
HyreCar Inc. Common Stock
HYRE
| $924K | ﹤0.01% |
+44,121
| New | +$678K |
|
2962
Bentley Systems
BSY
$10.7B
| $921K | ﹤0.01% |
+14,203
| New | +$781K |
|
2963
Zevra Therapeutics
ZVRA
$570M
| $920K | ﹤0.01% |
+71,732
| New | +$771K |
|
2964
Lineage Cell Therapeutics
LCTX
$277M
| $919K | ﹤0.01% |
322,361
+274,194
| +569% | +$709K |
|
2965
Legacy Housing
LEGH
$624M
| $919K | ﹤0.01% |
54,345
-1,731
| -3% | -$32K |
|
2966
Applied Optoelectronics
AAOI
$7.23B
| $917K | ﹤0.01% |
108,246
-53,132
| -33% | -$433K |
|
2967
Stagwell
STGW
$2.1B
| $910K | ﹤0.01% |
155,434
+132,562
| +580% | +$619K |
|
2968
Tonix Pharmaceuticals
TNXP
$161M
| $909K | ﹤0.01% |
+1
| New | +$735K |
|
|
APLT
2969
DELISTED
Applied Therapeutics
APLT
| $908K | ﹤0.01% |
43,653
+4,507
| +12% | +$85.3K |
|
2970
Sierra Bancorp
BSRR
$527M
| $908K | ﹤0.01% |
35,667
-390
| -1% | -$10.5K |
|
2971
GT Biopharma
GTBP
$11.1M
| $899K | ﹤0.01% |
+1,933
| New | +$803K |
|
2972
Century Casinos
CNTY
$33.2M
| $898K | ﹤0.01% |
66,846
+1,458
| +2% | +$19K |
|
2973
Foster
FSTR
$431M
| $887K | ﹤0.01% |
47,561
-20,239
| -30% | -$355K |
|
2974
Identive
INVE
$64.8M
| $887K | ﹤0.01% |
+52,119
| New | +$787K |
|
2975
Primis Financial Corp
FRST
$396M
| $884K | ﹤0.01% |
57,895
+9,550
| +20% | +$143K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.